National Asset Management Inc. Grows Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

National Asset Management Inc. raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) by 21.8% during the first quarter, HoldingsChannel.com reports. The firm owned 10,970 shares of the exchange traded fund’s stock after buying an additional 1,963 shares during the quarter. National Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $986,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Cerity Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $207,000. Credit Agricole S A acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $3,382,000. Pettinga Financial Advisors LLC grew its stake in shares of SPDR S&P Biotech ETF by 19.0% in the first quarter. Pettinga Financial Advisors LLC now owns 12,450 shares of the exchange traded fund’s stock valued at $1,119,000 after buying an additional 1,985 shares in the last quarter. KRS Capital Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $62,000. Finally, Cumberland Advisors Inc. grew its stake in shares of SPDR S&P Biotech ETF by 24.9% in the first quarter. Cumberland Advisors Inc. now owns 316,315 shares of the exchange traded fund’s stock valued at $28,430,000 after buying an additional 63,101 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 4.2 %

XBI stock opened at $80.68 on Monday. SPDR S&P Biotech ETF has a 1 year low of $61.78 and a 1 year high of $136.61. The stock has a 50-day simple moving average of $73.67 and a 200-day simple moving average of $82.79.

SPDR S&P Biotech ETF Profile

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.